Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Commensals upon us.

M N Alekshun1, S B Levy

  • 1Paratek Pharmaceuticals Inc., Boston, MA 02111, USA. malekshun@paratekpharm.com

Biochemical Pharmacology
|February 9, 2006
PubMed
Summary
This summary is machine-generated.

Antibiotic use and vaccines can lead to normally harmless bacteria becoming dangerous pathogens. This shift in bacterial infections impacts public health and requires new strategies to manage emerging infectious diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seasonal variation in basal metabolic rates among the Yakut (Sakha) of Northeastern Siberia.

American journal of human biology : the official journal of the Human Biology Council·2014
Same author

In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.

Antimicrobial agents and chemotherapy·2013
Same author

Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.

Antimicrobial agents and chemotherapy·2003
Same author

Active efflux, a common mechanism for biocide and antibiotic resistance.

Symposium series (Society for Applied Microbiology)·2002
Same author

Active efflux, a common mechanism for biocide and antibiotic resistance.

Journal of applied microbiology·2002
Same author

Beyond comparison--antibiotics from genome data?

Nature biotechnology·2001
Same journal

Mapk-driven remodeling of mitochondrial dynamics in melanoma: implications for metabolic plasticity and response to targeted therapy.

Biochemical pharmacology·2026
Same journal

Unraveling the multifaceted roles of the aryl hydrocarbon receptor in the central nervous system: neurogenesis, neural function, and disease.

Biochemical pharmacology·2026
Same journal

4-DMB, a diclofenac derivative, alleviates DSS-induced ulcerative colitis in mice by binding TNFR1 to inhibit inflammation.

Biochemical pharmacology·2026
Same journal

Calceolarioside B alleviates airway barrier dysfunction and inflammation via targeting P2Y<sub>6</sub>R in OVA-triggered asthma.

Biochemical pharmacology·2026
Same journal

The dual-faced pyruvate kinase M2 in tumors: From cytoplasmic metabolic gatekeeper to nuclear transcriptional coactivator.

Biochemical pharmacology·2026
Same journal

A [<sup>68</sup>Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens.

Biochemical pharmacology·2026
See all related articles

Area of Science:

  • Microbiology
  • Epidemiology
  • Evolutionary Biology

Background:

  • Antibiotic therapies and vaccines are crucial for combating bacterial infections.
  • Interventions targeting specific bacterial species may inadvertently affect the broader microbial ecosystem.
  • Commensal bacteria, normally harmless residents, are emerging as significant infectious agents.

Purpose of the Study:

  • To investigate the impact of antibiotic use and vaccination on the epidemiology of infections caused by commensal bacteria.
  • To identify shifts in pathogenicity among natural microbial flora due to clinical interventions.
  • To understand how evolutionary pressures from medical treatments promote the emergence of novel infectious disease threats.

Main Methods:

  • Review of clinical data and epidemiological surveillance of bacterial infections.

Related Experiment Videos

  • Analysis of antibiotic resistance patterns and vaccine escape strains.
  • Case studies of emerging pathogens from commensal flora.

    • Main Results:

    • Emergence of vancomycin-resistant enterococci (VRE) as a significant nosocomial pathogen.
    • Increased prevalence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
    • Identification of non-vaccine invasive serotypes of Streptococcus pneumoniae and new strains of non-type b Haemophilus influenzae.
    • Rise of multi-drug resistant Escherichia coli as a cause of infectious diseases.
    • Demonstration of evolutionary adaptation in commensal bacteria driven by antibiotic pressure.

    Conclusions:

    • Clinical interventions, including antibiotic use and vaccination, are driving the evolution of commensal bacteria into pathogenic strains.
    • These shifts in microbial populations pose new challenges to public health and infectious disease control.
    • Understanding these evolutionary dynamics is critical for developing effective strategies against emerging bacterial threats.